UBS Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8M | Sell |
1,163,894
-297,895
| -20% | -$5.07M | ﹤0.01% | 1858 |
|
|
2025
Q1 | $28.5M | Sell |
1,461,789
-357,847
| -20% | -$6.99M | 0.01% | 1547 |
|
|
2024
Q4 | $45.1M | Buy |
1,819,636
+1,630,442
| +862% | +$40.4M | 0.01% | 1183 |
|
|
2024
Q3 | $4.64M | Buy |
189,194
+26,617
| +16% | +$652K | ﹤0.01% | 2338 |
|
|
2024
Q2 | $3.81M | Sell |
162,577
-87,664
| -35% | -$2.05M | ﹤0.01% | 2333 |
|
|
2024
Q1 | $8.27M | Sell |
250,241
-10,259
| -4% | -$339K | ﹤0.01% | 1745 |
|
|
2023
Q4 | $7.09M | Buy |
260,500
+141,102
| +118% | +$3.84M | ﹤0.01% | 1692 |
|
|
2023
Q3 | $2.87M | Sell |
119,398
-7,808
| -6% | -$188K | ﹤0.01% | 2267 |
|
|
2023
Q2 | $4.06M | Buy |
127,206
+73,921
| +139% | +$2.36M | ﹤0.01% | 2075 |
|
|
2023
Q1 | $1.63M | Sell |
53,285
-85,420
| -62% | -$2.62M | ﹤0.01% | 2772 |
|
|
2022
Q4 | $5.42M | Buy |
138,705
+130,546
| +1,600% | +$5.11M | ﹤0.01% | 1777 |
|
|
2022
Q3 | $389K | Sell |
8,159
-31,393
| -79% | -$1.5M | ﹤0.01% | 3572 |
|
|
2022
Q2 | $1.53M | Sell |
39,552
-26,206
| -40% | -$1.01M | ﹤0.01% | 2567 |
|
|
2022
Q1 | $3.77M | Buy |
65,758
+27,174
| +70% | +$1.56M | ﹤0.01% | 2154 |
|
|
2021
Q4 | $3.08M | Sell |
38,584
-10,167
| -21% | -$810K | ﹤0.01% | 2521 |
|
|
2021
Q3 | $4.24M | Buy |
48,751
+19,781
| +68% | +$1.72M | ﹤0.01% | 2152 |
|
|
2021
Q2 | $3.73M | Sell |
28,970
-9,559
| -25% | -$1.23M | ﹤0.01% | 2248 |
|
|
2021
Q1 | $3.08M | Buy |
38,529
+16,773
| +77% | +$1.34M | ﹤0.01% | 2376 |
|
|
2020
Q4 | $1.78M | Buy |
21,756
+17,295
| +388% | +$1.41M | ﹤0.01% | 2717 |
|
|
2020
Q3 | $110K | Sell |
4,461
-2,774
| -38% | -$68.4K | ﹤0.01% | 4300 |
|
|
2020
Q2 | $203K | Buy |
7,235
+6,435
| +804% | +$181K | ﹤0.01% | 3991 |
|
|
2020
Q1 | $14K | Buy |
+800
| New | +$14K | ﹤0.01% | 5804 |
|